Connected Health, founded by the Science Park Tehnopol, is a country-wide partnership between health-related stakeholders in Estonia, who are committed to accelerating the adoption of connected health solutions, on an international scale and on commercial terms. The cluster brings together 80+ partners, including 43 companies (start-ups, health IT, medtech, biotech, and pharma), R&D partners (universities and technology competence centres), health and wellness service providers (hospitals, GPs, occupational health, spas, fitness and sports), patient organisations and user communities, and public sector (ministries responsible for healthcare and entrepreneurship, national health insurance, and the national health development agency).

• For over 13 years Goodpoint Chemicals has designed, developed and produced high-quality and user-friendly products for medical institutions with a wide efficacy spectrum, that have been tested in accredited laboratories. Over 15 of our products are CE-certified. We have long-time partnerships with Lonza, BASF, Brill&Partner GmbH, Robert Koch Institute, Eurofins and University of Bonn. Our latest products are wound irrigation solution Globasept®Wound Sol. and highly demanded chlorhexidine-based antiseptics.

Icosagen is a research-driven contract research, development and manufacturing company for diagnostic, biopharmaceutical and biotechnology industry. We offer hundreds of off-the-shelf diagnostic antibodies and antigens, custom-tailored services on antibody development, recombinant protein production and stable CHO cell line development. We are a trusted European biotechnology company with more than 20 years of supply experience. Icosagen is ISO9001:2015 certified and follows GLP guidelines.

Migrevention is a an Estonian health technology company and Estonia’s first software based medical device manufacturer. Migrevention is a fully digital headache clinic and we offer digital solutions for patients, specialists and clinics to monitor, diagnose and treat migraine and other primary headaches. Migrevention’s mission is raising awareness and providing more accessible treatment to over 1.4B migraine patients in the world through digital therapeutics. At the moment, only 1-4% of migraine patients get evidence-based treatment, and the vast majority stays undiagnosed and untreated. Without sufficient treatment, the medical costs add up to 155 billion € per year only in the EU; and risks for migraine chronification, secondary health problems, and medication overuse headache rise drastically.

Respiray is an Estonian technology company dedicated to creating wearable devices that help people live healthier lives. Our first product was developed to provide protection from airborne viruses, and we are now launching Respiray Wear A+, which helps people who suffer from allergies. From pet dander to pollen, all airborne allergens are filtered out by our latest innovation, which was developed by an international team of scientists, engineers and designers and is produced in accordance with the highest European manufacturing standards by an Estonia-based company.

Triumf Health is providing an evidence-based digital therapeutics platform for children to deliver personalized psychological support through a game environment. The game named Triumfland Saga is for kids aged 7-12. Available in multiple languages. For Android and iOS. Distributed institutionally mainly through schools, hospitals, insurance provides.

Bioatlas has focused on the development of PCR and agarose gel electrophoresis reagents for over 15 years. Our main goal is to revolutionize agarose gel preparation around the world with the help of our partners. Our safe DNA stains and patented tablet technology are already introduced to many countries and numerous institutions, including educational system in USA.

Dermtest saves lives and time by enabling visual data management in healthcare, instead of burdensome text-based documentation. The core of Dermtest is a powerful medical photo management B2B SaaS platform, used by 75 paying hospitals and clinics for various value-creating use-cases in Germany and Estonia. Dermtest supports the whole care pathway across care levels from GPs to hospitals, from home care to nursing homes.

CoNurse provides step-by-step nursing guidelines that help to improve the quality of care and prevent adverse events. Content creation and management makes keeping protocols up-to-date effortless and enables data-based decision making. SpeakTX is a speech therapy platform. It makes the therapy process more interesting and engaging for the patients and provides support to the specialists. The main features are interactive exercises, exercise plans, video consultations and a marketplace.

Activate Health is re-imagining the prevention of heart disease with evidence-based digital therapeutics (DTx) that combine remote diagnostics with AI-guided clinical lifestyle intervention programs. We empower people to take better control of their heart health while helping payers and providers save cost and improve outcomes at scale. We are currently running a 1 million euro R&D project financed by Enterprise Estonia together with our scientific research partners Estonian Biobank, SYNLAB & University of Tartu.

Equipped with Artificial Intelligence (AI), our tools enable doctors to detect and diagnose cancer in more efficient and accurate ways. We are a deep-tech company in the imaging diagnostics space aiming to cover a wide range of cancers in the human body. Better Medicine’s mission is to give superpowers to radiologists for interpretation and reporting through the use of new technologies. We will be optimizing oncology diagnostics workflows in imaging by supporting radiologists with tumor detection & measurements, tracking disease dynamics over time, enabling structured and standardized reporting.